Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome

Proteomics

Volumn 10, Issue 14, 2010, Pages 2620-2630

  Ding, Ying ^a   Lu, Bin ^a   Chen, Dongbo ^b   Meng, Lina ^a   Shen, Yan ^a   Chen, Shuo ^c  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Beijing Proteome Research Center   (China)

Author keywords

Animal proteomics; DIGE; Irritable bowel syndrome; MALDI TOF MS MS

Indexed keywords

ALPHA ENOLASE; CATHEPSIN; CYTOKERATIN 8; GLYOXALASE; PEROXIREDOXIN 6; PROTEIN DISULFIDE ISOMERASE; TRANSGELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; GEL ELECTROPHORESIS; IRRITABLE COLON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; PROTEINS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SUBCELLULAR FRACTIONS;

ANIMALIA; RATTUS;

EID: 77954709516     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900572     Document Type: Article

References (69)

1. Mertz, H. R., Irritable bowel syndrome. N. Engl. J. Med. 2003, 349, 2136-2146.
2. Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A. et al., Functional bowel disorders. Gastroenterology 2006, 130, 1480-1491.
3. Lee, S. Y., Kim, J. H., Sung, I. K., Park, H. S. et al., Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II-based survey. J. Korean Med. Sci. 2007, 22, 851-854.
4. Roberts, S. E., Williams, J. G., Yeates, D., Goldacre, M. J., Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007, 335, 1033.
5. Cohen, R. D., Thomas, T., Economics of the use of biologics in the treatment of inflammatory bowel disease. Gastroenterol. Clin. North Am. 2006, 35, 867-882.
6. Cremonini, F., Talley, N. J., Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol. Clin. North Am. 2005, 34, 189-204.
7. Pan, G. Z., Lu, S. C., Ke, M. Y., Han, S. M. et al., An epidemiologic study of irritable bowel syndrome in Beijing: A stratified randomized study by clustering sampling. Chin. J. Epidemiol. 2000, 21, 26-29.
8. Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E. et al., The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122, 1500-1511.
9. Foxx-Orenstein, A., IBS - review and what's new. MedGenMed 2006, 8, 20.
10. Camilleri, M., Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol. Motil. 2005, 17, 311-316.
11. Cann, P. A., Read, N. W., Brown, C., Hobson, N., Holdsworth, C. D., Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983, 24, 405-411.
12. Vassallo, M., Camilleri, M., Phillips, S. F., Brown, M. L. et al., Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 1992, 102, 102-108.
13. Stivland, T., Camilleri, M., Vassallo, M., Proano, M. et al., Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991, 101, 107-115.
14. Choi, M. G., Camilleri, M., O'Brien, M. D., Kammer, P. P., Hanson, R. B., A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am. J. Gastroenterol. 1997, 92, 297-302.
15. O'Brien, M. D., Camilleri, M., von der Ohe, M. R., Phillips, S. F. et al., Motility and tone of the left colon in constipation: a role in clinical practice? Am. J. Gastroenterol. 1996, 91, 2532-2538.
16. Mertz, H., Naliboff, B., Munakata, J., Niazi, N., Mayer, E. A., Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109, 40-52.
17. Bouin, M., Plourde, V., Boivin, M., Riberdy, M. et al., Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002, 122, 1771-1777.
18. Mertz, H., Morgan, V., Tanner, G., Pickens, D. et al., Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000, 118, 842-848.
19. Mayer, E. A., Naliboff, B. D., Craig, A. D., Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006, 131, 1925-1942.
20. Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C. et al., Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 2005, 3, 349-357.
21. Dunlop, S. P., Hebden, J., Campbell, E., Naesdal, J. et al., Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am. J. Gastroenterol. 2006, 101, 1288-1294.
22. Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., Houghton, L. A., Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006, 130, 34-43. (Pubitemid 43049833)
23. Gwee, K. A., Graham, J. C., McKendrick, M. W., Collins, S. M. et al., Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996, 347, 150-153. (Pubitemid 26025154)
24. Barbara, G., Wang, B., Stanghellini, V., de Giorgio, R. et al., Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132, 26-37.
25. Chadwick, V. S., Chen, W., Shu, D., Paulus, B. et al., Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122, 1778-1783. (Pubitemid 34651421)
26. Gwee, K. A., Collins, S. M., Read, N. W., Rajnakova, A. et al., Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52, 523-526.
27. Holmen, N., Isaksson, S., Simren, M., Sjovall, H., Ohman, L., CD4+CD25+regulatory T cells in irritable bowel syndrome patients. Neurogastroenterol. Motil. 2007, 19, 119-125.
28. Srinivas, P. R., Kramer, B. S., Srivastava, S., Trends in biomarker research for cancer detection. Lancet Oncol. 2001, 2, 698-704. (Pubitemid 33085816)
29. Lopes, L. V., Marvin-Guy, L. F., Fuerholz, A., Affolter, M. et al., Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life. J. Proteomics 2008, 71, 80-88. (Pubitemid 351697864)
30. Plourde, V., St-Pierre, S., Quirion, R., Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am. J. Physiol. 1997, 273, G191-G196.
31. Barreau, F., Cartier, C., Ferrier, L., Fioramonti, J., Bueno, L., Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology 2004, 127, 524-534. (Pubitemid 39091901)
32. Al-Chaer, E. D., Kawasaki, M., Pasricha, P. J., A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000, 119, 1276-1285.
33. Liu, Y. B., Yuan, Y. Z., Tao, R. J., Zhai, Z. K., Chen, H. Z., Establishment of a rat model of gut hypersensitivity and for evaluation of visceral sensitivity. Chin. J. Dig. 2003, 23, 34-37.
34. Minowa, T., Ohtsuka, S., Sasai, H., Kamada, M., Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis. Electrophoresis 2000, 21, 1782-1786.
35. Alban, A., David, S. O., Bjorkesten, L., Andersson, C. et al., A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
36. Canals, F., Colome, N., Ferrer, C., Plaza-Calonge Mdel, C., Rodriguez-Manzaneque, J. C., Identification of substrates of the extracellular protease ADAMTS1 by DIGE proteomic analysis. Proteomics 2006, 6, S28-S35.
37. La, J. H., Kim, T. W., Sung, T. S., Kim, H. J. et al., Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J. Vet. Sci. 2004, 5, 319-324.
38. Lu, H., Wang, W. A., Qian, J. M., The evaluation of visceral sensation in traditional restraint wrap stress animal mode. J. Gastroenterol. Hepatol. 2005, 14, 111-113.
39. La, J. H., Kim, T. W., Sung, T. S., Kim, H. J. et al., Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome. World J. Gastroenterol. 2005, 11, 237-241.
40. Xu, J. R., Luo, J. Y., Shang, L., Kong, W. M., Role of inhibitory neurotransmitter of myoenteric plexus in carcinogenesis of irritable bowel syndrome with different subtypes. World Chin. J. Digestol. (Chin.) 2005, 13, 2332-2338.
41. Li, D., Li, J.-Q., Ouyang, S.-G., Wu, S.-F. et al., An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Prog. Biochem. Biophys. 2005, 32, 1026-1029.
42. Freedman, R. B., Hirst, T. R., Tuite, M. F., Protein disulphide isomerase: building bridges in protein folding. Trends Biochem. Sci. 1994, 19, 331-336.
43. Wearsch, P. A., Cresswell, P., Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat. Immunol. 2007, 8, 873-881.
44. Antoniou, A. N., Santos, S. G., Campbell, E. C., Lynch, S. et al., ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove. FEBS Lett. 2007, 581, 1988-1992.
45. Barbara, G., De Giorgio, R., Stanghellini, V., Cremon, C. et al., New pathophysiological mechanisms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2004, 20, 1-9.
46. Cremon, C., Gargano, L., Morselli-Labate, A. M., Santini, D. et al., Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am. J. Gastroenterol. 2009, 104, 392-400.
47. Moll, R., Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochem. Suppl. 1991, 41, 117-127.
48. Baribault, H., Penner, J., Iozzo, R. V., Wilson-Heiner, M., Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 1994, 8, 2964-2973.
49. Toivola, D. M., Krishnan, S., Binder, H. J., Singh, S. K., Omary, M. B., Keratins modulate colonocyte electrolyte transport via protein mistargeting. J. Cell Biol. 2004, 164, 911-921.
50. Owens, D. W., Wilson, N. J., Hill, A. J., Rugg, E. L. et al., Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J. Cell Sci. 2004, 117, 1989-1999.
51. Habtezion, A., Toivola, D. M., Butcher, E. C., Omary, M. B., Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J. Cell Sci. 2005, 118, 1971-1980.
52. Park, H., The pathophysiology of irritable bowel syndrome: inflammation and motor disorder. Korean J. Gastroenterol. 2006, 47, 101-110.
53. Rhee, S. G., Chae, H. Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38, 1543-1552.
54. Manevich, Y., Fisher, A. B., Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic. Biol. Med. 2005, 38, 1422-1432.
55. Phelan, S. A., AOP2 (antioxidant protein 2): structure and function of a unique thiol-specific antioxidant. Antioxid. Redox Signal. 1999, 1, 571-584.
56. Fisher, A. B., Dodia, C., Manevich, Y., Chen, J. W., Feinstein, S. I., Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J. Biol. Chem. 1999, 274, 21326-21334.
57. Kumin, A., Huber, C., Rulicke, T., Wolf, E., Werner, S., Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am. J. Pathol. 2006, 169, 1194-1205.
58. Pereda, J., Sabater, L., Aparisi, L., Escobar, J. et al., Interaction between cytokines and oxidative stress in acute pancreatitis. Curr. Med. Chem. 2006, 13, 2775-2787.
59. Barclay, J., Clark, A. K., Ganju, P., Gentry, C. et al., Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain 2007, 130, 225-234.
60. Piast, M., Kustrzeba-Wojcicka, I., Matusiewicz, M., Banas, T., Molecular evolution of enolase. Acta Biochim. Pol. 2005, 52, 507-513.
61. Pancholi, V., Multifunctional alpha-enolase: its role in diseases. Cell Mol. Life Sci. 2001, 58, 902-920.
62. Welberg, L. A., Seckl, J. R., Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 2001, 13, 113-128.
63. Cassar-Malek, I., Listral, A., Picard, B., Contrôle hormonal des caractéristiques des fibres musculaires après la naissance. Prod. Anim. 1998, 11, 365-377.
64. Biagini, G., Pich, E. M., Carani, C., Marrama, P., Agnati, L. F., Postnatal maternal separation during the stress hyporesponsive period enhances the adrenocortical response to novelty in adult rats by affecting feedback regulation in the CA1 hippocampal field. Int. J. Dev. Neurosci. 1998, 16, 187-197.
65. Brindley, D. N., Rolland, Y., Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci. (Lond.) 1989, 77, 453-461.
66. Francis, D. D., Meaney, M. J., Maternal care and the development of stress responses. Curr. Opin. Neurobiol. 1999, 9, 128-134.
67. Francis, D. D., Caldji, C., Champagne, F., Plotsky, P. M., Meaney, M. J., The role of corticotropin-releasing factor - norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress. Biol. Psychiatry 1999, 46, 1153-1166.
68. Gregoire, F., Genart, C., Hauser, N., Remacle, C., Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors. Exp. Cell Res. 1991, 196, 270-278.
69. Lan, N. C., Karin, M., Nguyen, T., Weisz, A. et al., Mechanisms of glucocorticoid hormone action. J. Steroid Biochem. 1984, 20, 77-88.